CNN Sanjay Gupta MD June 16, 2013 11:43:00
Exclusively market the tests, which by the way, costs about $4,000. it's interesting. it was a nuance decision. i know you read it as well. how does that work and what do you think this means for patients, your patients, for example? >> well, you know, it was a very interesting decision. they protected myriad's right, but they also gave patients rights also, and that is to say that, you know, nobody really owns your genes. but still, i think there's some level of recognition that in order to get to a product that we can do a test against, that there is some innovation that goes into that. and ...